Quanterix Corporation
US ˙ NasdaqGM ˙ US74766Q1013

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Brian J Blaser. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Brian J Blaser reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
President and CEO 35,649
US:QTRX / Quanterix Corporation Director 19,049
US:RKLY / Rockley Photonics Holdings Ltd Director 54,393
US:TLIS / Talis Biomedical Corporation President and CEO, Director 625,000
US:ABT / Abbott Laboratories Executive Vice President 300,000
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Brian J Blaser. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas QTRX / Quanterix Corporation - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em QTRX / Quanterix Corporation. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

QTRX / Quanterix Corporation Insider Trades
Vendas Internas QTRX / Quanterix Corporation - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em QTRX / Quanterix Corporation. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

QTRX / Quanterix Corporation Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Brian J Blaser conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2026-05-19 2026-05-15 4 QDEL QuidelOrtho Corp
Common Stock
F - Taxes -10,252 35,649 -22.34 10.32 -105,801 367,898
2026-05-19 2026-05-15 4 QDEL QuidelOrtho Corp
Common Stock
A - Award 20,759 45,901 82.57
2026-02-13 2026-02-13 4 QDEL QuidelOrtho Corp
Common Stock
P - Purchase 10,540 40,073 35.69 23.59 248,661 945,406
2026-02-02 2026-01-29 4 QDEL QuidelOrtho Corp
Common Stock
F - Taxes -7,755 25,142 -23.57 27.41 -212,565 689,142
2026-02-02 2026-01-29 4 QDEL QuidelOrtho Corp
Common Stock
A - Award 21,446 32,897 187.28
2025-11-20 2025-11-19 4 QDEL QuidelOrtho Corp
Common Stock
P - Purchase 23,500 29,533 389.52 21.34 501,577 630,343
2025-05-19 2025-05-15 4 QDEL QuidelOrtho Corp
Common Stock
F - Taxes -9,308 11,451 -44.84 33.03 -307,443 378,227
2025-05-19 2025-05-15 4 QDEL QuidelOrtho Corp
Common Stock
A - Award 20,759 20,759
2024-12-13 2024-12-11 4 QDEL QuidelOrtho Corp
Common Stock
P - Purchase 6,033 6,033 41.42 249,878 249,878
2024-01-04 2024-01-02 4 QTRX Quanterix Corp
Common Stock
A - Award 2,947 19,049 18.30
2023-01-09 2023-01-06 4 QTRX Quanterix Corp
Common Stock
A - Award 16,102 16,102
2022-06-08 2022-05-16 4 RKLY Rockley Photonics Holdings Ltd
Ordinary Share
M - Exercise 7,333 54,393 15.58
2022-03-25 2022-03-18 4/A RKLY Rockley Photonics Holdings Ltd
Ordinary Share
P - Purchase 47,060 69,060 213.91 4.19 197,370 289,638
2022-03-18 2022-03-18 4 RKLY Rockley Photonics Holdings Ltd
Ordinary Share
P - Purchase 47,060 22,000 -187.79 4.19 197,370 92,268
2021-12-02 2021-12-01 4 TLIS Talis Biomedical Corp
Restricted Stock Units
A - Award 625,000 625,000
2021-12-02 2021-12-01 4 TLIS Talis Biomedical Corp
Stock Option (right to buy)
A - Award 750,000 750,000
2021-10-20 2021-10-18 4 RKLY Rockley Photonics Holdings Ltd
Restricted Stock Unit
A - Award 22,000 22,000 7.14 157,080 157,080
2019-05-24 2019-05-23 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -56,735 300,000 -15.90
2019-05-24 2019-05-23 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -53,163 120,000 -30.70
2019-05-24 2019-05-23 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -175,164 0 -100.00
2019-05-24 2019-05-23 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -165,000 0 -100.00
2019-05-24 2019-05-23 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -450,062 130,745 -77.49 75.52 -33,988,727 9,873,875
2019-05-24 2019-05-23 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 56,735 580,807 10.83 38.40 2,178,624 22,302,989
2019-05-24 2019-05-23 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 53,163 524,072 11.29 47.00 2,498,661 24,631,384
2019-05-24 2019-05-23 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 175,164 470,909 59.23 39.12 6,852,416 18,421,960
2019-05-24 2019-05-23 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 165,000 295,745 126.20 34.94 5,765,100 10,333,330
2019-03-04 2019-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,177 130,745 -0.89 78.21 -92,053 10,225,566
2019-03-04 2019-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -5,736 131,922 -4.17 78.21 -448,618 10,317,752
2019-03-04 2019-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,100 137,658 -0.79 78.22 -86,042 10,767,609
2019-03-04 2019-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -300 138,758 -0.22 78.22 -23,466 10,853,790
2019-03-04 2019-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,900 139,058 -1.35 78.23 -148,637 10,878,507
2019-03-04 2019-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -3,642 140,958 -2.52 78.24 -284,950 11,028,554
2019-03-04 2019-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -600 144,600 -0.41 78.24 -46,945 11,313,649
2019-03-04 2019-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,400 145,200 -0.95 78.25 -109,550 11,361,900
2019-03-04 2019-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -300 146,600 -0.20 78.25 -23,475 11,471,597
2019-03-04 2019-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -14,663 146,900 -9.08 77.23 -1,132,423 11,345,087
2019-02-26 2019-02-22 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 148,895 148,895
2019-02-26 2019-02-22 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 28,405 161,563 21.33
2018-12-21 2018-12-21 4 ABT ABBOTT LABORATORIES
Common shares without par value
G - Gift -60 133,158 -0.05
2018-12-21 2018-12-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
G - Gift -3,600 133,218 -2.63
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -10,100 0 -100.00
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -48,100 0 -100.00
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -100 136,818 -0.07 68.84 -6,884 9,419,235
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -3,214 136,918 -2.29 68.84 -221,252 9,425,435
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -960 140,132 -0.68 68.84 -66,082 9,645,986
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -6,240 141,092 -4.24 68.83 -429,499 9,711,362
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -2,000 147,332 -1.34 68.82 -137,650 10,140,125
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -5,800 149,332 -3.74 68.82 -399,156 10,277,028
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,136 155,132 -0.73 68.82 -78,174 10,675,409
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -4,522 156,268 -2.81 68.81 -311,159 10,752,801
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,442 160,790 -0.89 68.80 -99,217 11,063,156
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,500 162,232 -0.92 68.80 -103,200 11,161,562
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,100 163,732 -0.67 68.80 -75,674 11,263,943
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -7,807 164,832 -4.52 68.79 -537,044 11,338,793
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -2,300 172,639 -1.31 68.78 -158,206 11,874,974
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -2,400 174,939 -1.35 68.78 -165,072 12,032,304
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -3,822 177,339 -2.11 68.78 -262,858 12,196,490
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -3,020 181,161 -1.64 68.77 -207,685 12,458,442
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,837 184,181 -0.99 68.76 -126,321 12,665,206
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,757 186,018 -0.94 68.76 -120,811 12,790,598
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -2,043 187,775 -1.08 68.76 -140,466 12,910,470
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -800 189,818 -0.42 68.75 -55,000 13,049,988
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,250 190,618 -0.65 68.74 -85,931 13,104,034
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,800 191,868 -0.93 68.74 -123,732 13,189,006
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -100 193,668 -0.05 68.74 -6,874 13,312,254
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -350 193,768 -0.18 68.74 -24,057 13,318,643
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -900 194,118 -0.46 68.73 -61,857 13,341,730
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 10,100 195,018 5.46 29.29 295,849 5,712,467
2018-09-21 2018-09-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 48,100 184,918 35.16 27.03 1,300,316 4,998,999
2018-07-26 2018-07-24 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -200 136,818 -0.15 63.98 -12,797 8,754,300
2018-07-26 2018-07-24 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -2,440 137,018 -1.75 63.98 -156,111 8,766,412
2018-07-26 2018-07-24 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -600 139,458 -0.43 63.98 -38,385 8,921,826
2018-07-26 2018-07-24 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -3,560 140,058 -2.48 63.97 -227,733 8,959,510
2018-07-26 2018-07-24 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -520 143,618 -0.36 63.96 -33,262 9,186,525
2018-07-26 2018-07-24 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,910 144,138 -1.31 63.96 -122,164 9,219,066
2018-07-26 2018-07-24 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -3,278 146,048 -2.20 63.96 -209,644 9,340,500
2018-07-26 2018-07-24 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -608 149,326 -0.41 63.95 -38,882 9,549,398
2018-07-26 2018-07-24 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -484 149,934 -0.32 63.94 -30,949 9,587,530
2018-07-26 2018-07-24 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -100 150,418 -0.07 63.94 -6,394 9,617,727
2018-07-26 2018-07-24 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -100 150,518 -0.07 63.92 -6,392 9,621,863
2018-07-26 2018-07-24 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -200 150,618 -0.13 63.92 -12,784 9,627,503
2018-07-26 2018-07-24 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -300 150,818 -0.20 63.92 -19,174 9,639,532
2018-07-26 2018-07-24 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -100 151,118 -0.07 63.91 -6,391 9,657,951
2018-07-26 2018-07-24 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -200 151,218 -0.13 63.90 -12,781 9,663,586
2018-07-26 2018-07-24 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -100 151,418 -0.07 63.90 -6,390 9,675,610
2018-07-26 2018-07-24 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -200 151,518 -0.13 63.89 -12,778 9,680,485
2018-07-26 2018-07-24 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -200 151,718 -0.13 63.88 -12,777 9,692,504
2018-03-02 2018-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -13,529 151,918 -8.18 60.55 -819,181 9,198,635
2018-02-21 2018-02-16 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 201,229 201,229
2018-02-21 2018-02-16 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 36,593 165,447 28.40
2018-02-01 2018-01-31 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -27,733 0 -100.00
2018-02-01 2018-01-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -100 128,854 -0.08 62.29 -6,229 8,026,316
2018-02-01 2018-01-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -600 128,954 -0.46 62.28 -37,371 8,031,900
2018-02-01 2018-01-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -400 129,554 -0.31 62.28 -24,912 8,068,623
2018-02-01 2018-01-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,340 129,954 -1.02 62.28 -83,448 8,092,885
2018-02-01 2018-01-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -5,660 131,294 -4.13 62.27 -352,448 8,175,677
2018-02-01 2018-01-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -2,501 136,954 -1.79 62.26 -155,725 8,527,441
2018-02-01 2018-01-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -4,613 139,455 -3.20 62.26 -287,205 8,682,468
2018-02-01 2018-01-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -2,931 144,068 -1.99 62.26 -182,469 8,968,953
2018-02-01 2018-01-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -6,400 146,999 -4.17 62.25 -398,400 9,150,688
2018-02-01 2018-01-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,798 153,399 -1.16 62.24 -111,917 9,548,321
2018-02-01 2018-01-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -500 155,197 -0.32 62.24 -31,120 9,659,461
2018-02-01 2018-01-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -890 155,697 -0.57 62.24 -55,389 9,689,803
2018-02-01 2018-01-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 27,733 156,587 21.52 22.39 620,995 3,506,280
2017-11-20 2017-11-17 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -6,333 0 -100.00
2017-11-20 2017-11-17 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -3,233 0 -100.00
2017-11-20 2017-11-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -10,287 128,854 -7.39 55.54 -571,289 7,155,907
2017-11-20 2017-11-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -200 139,141 -0.14 55.53 -11,106 7,726,792
2017-11-20 2017-11-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -200 139,341 -0.14 55.53 -11,106 7,737,884
2017-11-20 2017-11-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -713 139,541 -0.51 55.53 -39,594 7,748,851
2017-11-20 2017-11-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -900 140,254 -0.64 55.53 -49,977 7,788,319
2017-11-20 2017-11-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -2,000 141,154 -1.40 55.53 -111,060 7,838,282
2017-11-20 2017-11-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,922 143,154 -1.32 55.56 -106,796 7,954,352
2017-11-20 2017-11-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -3,944 145,076 -2.65 55.57 -219,168 8,061,873
2017-11-20 2017-11-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,000 149,020 -0.67 55.57 -55,571 8,281,190
2017-11-20 2017-11-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -2,700 150,020 -1.77 55.58 -150,052 8,337,362
2017-11-20 2017-11-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 6,333 152,720 4.33 23.23 147,103 3,547,380
2017-11-20 2017-11-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 3,233 146,387 2.26 26.19 84,665 3,833,568
2017-07-28 2017-07-27 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -15,000 143,154 -9.48 50.00 -750,000 7,157,700
2017-03-02 2017-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -13,259 158,154 -7.74 45.46 -602,754 7,189,681
2017-02-22 2017-02-17 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 182,242 182,242
2017-02-22 2017-02-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 26,351 171,413 18.17
2016-12-21 2016-12-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
P - Purchase 100 145,062 0.07 38.44 3,844 5,575,893
2016-12-21 2016-12-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
P - Purchase 2,072 144,962 1.45 38.44 79,648 5,572,339
2016-12-21 2016-12-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
P - Purchase 3,400 142,890 2.44 38.45 130,730 5,494,120
2016-12-21 2016-12-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
P - Purchase 9,708 139,490 7.48 38.46 373,370 5,364,785
2016-12-21 2016-12-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
P - Purchase 300 129,782 0.23 38.43 11,529 4,987,522
2016-03-02 2016-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,543 129,482 -1.18 39.29 -60,626 5,087,477
2016-03-02 2016-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -11,859 131,025 -8.30 39.52 -468,668 5,178,108
2016-02-23 2016-02-19 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 356,735 356,735
2016-02-23 2016-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 40,690 142,884 39.82
2015-07-30 2015-07-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -500 102,194 -0.49 50.98 -25,492 5,210,157
2015-07-30 2015-07-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -200 102,694 -0.19 50.98 -10,196 5,235,443
2015-07-30 2015-07-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,000 102,894 -0.96 50.98 -50,980 5,245,536
2015-07-30 2015-07-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -200 103,894 -0.19 50.97 -10,194 5,295,581
2015-07-30 2015-07-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,000 104,094 -0.95 50.97 -50,970 5,305,671
2015-07-30 2015-07-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -8,400 105,094 -7.40 50.96 -428,072 5,355,695
2015-06-03 2015-06-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -838 113,494 -0.73 48.60 -40,727 5,515,808
2015-03-03 2015-02-27 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -12,276 114,332 -9.70 47.61 -584,460 5,443,347
2015-02-24 2015-02-20 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 173,163 173,163
2015-02-24 2015-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 24,574 126,608 24.08
2014-06-02 2014-06-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -861 102,034 -0.84 40.01 -34,449 4,082,380
2014-03-04 2014-03-03 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,441 102,895 -1.38 39.01 -56,219 4,014,346
2014-03-04 2014-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -13,097 104,336 -11.15 39.79 -521,130 4,151,529
2014-02-25 2014-02-21 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 175,164 175,164
2014-02-25 2014-02-21 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 28,611 117,433 32.21
2013-06-04 2013-06-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -862 88,822 -0.96 36.67 -31,610 3,257,103
2013-05-20 2013-05-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -8,608 89,684 -8.76 36.83 -317,033 3,303,062
2013-03-01 2013-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -9,845 98,292 -9.10 34.26 -337,290 3,367,484
2013-02-20 2013-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,022 108,137 -0.94 34.79 -35,558 3,762,411
2013-02-20 2013-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -2,265 109,159 -2.03 35.08 -79,456 3,829,298
2013-02-20 2013-02-15 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 165,000 165,000
2013-02-20 2013-02-15 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 31,700 111,424 39.76
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -100 79,724 -0.13 64.60 -6,460 5,149,772
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -800 79,824 -0.99 64.59 -51,672 5,155,832
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -300 80,624 -0.37 64.58 -19,376 5,207,101
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,700 80,924 -2.06 64.56 -109,752 5,224,453
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,500 82,624 -1.78 64.56 -96,832 5,333,792
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -400 84,124 -0.47 64.54 -25,818 5,429,784
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,154 84,524 -1.35 64.54 -74,479 5,455,179
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -900 85,678 -1.04 64.54 -58,082 5,529,230
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -3,000 86,578 -3.35 64.53 -193,590 5,586,878
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,600 89,578 -1.75 64.52 -103,240 5,780,020
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,800 91,178 -1.94 64.52 -116,136 5,882,805
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -700 92,978 -0.75 64.52 -45,160 5,998,476
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,400 93,678 -1.47 64.51 -90,314 6,043,168
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -100 95,078 -0.11 64.51 -6,451 6,133,387
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -2,100 95,178 -2.16 64.50 -135,460 6,139,457
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,700 97,278 -1.72 64.50 -109,650 6,274,431
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -100 98,978 -0.10 64.50 -6,450 6,383,834
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,600 99,078 -1.59 64.50 -103,192 6,390,036
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -5,300 100,678 -5.00 64.49 -341,797 6,492,724
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -100 105,978 -0.09 64.49 -6,449 6,834,415
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -13,867 27,733 -33.33
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -12,667 6,333 -66.67
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -6,467 3,233 -66.67
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -12,800 0 -100.00
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -5,800 0 -100.00
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -5,700 0 -100.00
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -3,800 0 -100.00
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -3,000 0 -100.00
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,100 106,078 -1.03 64.48 -70,934 6,840,440
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -5,247 107,178 -4.67 64.48 -338,327 6,910,837
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -100 112,425 -0.09 64.48 -6,448 7,248,883
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -3,900 112,525 -3.35 64.48 -251,452 7,255,049
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -4,600 116,425 -3.80 64.47 -296,562 7,505,920
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -200 121,025 -0.16 64.47 -12,894 7,802,179
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -500 121,225 -0.41 64.46 -32,232 7,814,770
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -2,100 121,725 -1.70 64.46 -135,366 7,846,394
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,300 123,825 -1.04 64.46 -83,792 7,981,140
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -3,800 125,125 -2.95 64.45 -244,910 8,064,306
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -100 128,925 -0.08 64.45 -6,445 8,309,087
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -100 129,025 -0.08 64.45 -6,445 8,315,339
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,700 129,125 -1.30 64.44 -109,556 8,321,461
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -3,900 130,825 -2.89 64.44 -251,316 8,430,363
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,600 134,725 -1.17 64.44 -103,096 8,681,005
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -2,200 136,325 -1.59 64.43 -141,746 8,783,420
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -100 138,525 -0.07 64.43 -6,443 8,924,819
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,300 138,625 -0.93 64.42 -83,752 8,930,916
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -2,100 139,925 -1.48 64.42 -135,282 9,013,968
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -100 142,025 -0.07 64.42 -6,442 9,148,895
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -400 142,125 -0.28 64.42 -25,766 9,154,982
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,300 142,525 -0.90 64.40 -83,726 9,179,323
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 13,867 143,825 10.67 46.60 646,202 6,702,245
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 12,667 129,958 10.80 48.34 612,323 6,282,170
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 6,467 117,291 5.84 54.50 352,452 6,392,360
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 12,800 110,824 13.06 54.14 692,992 6,000,011
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 5,800 98,024 6.29 55.56 322,248 5,446,213
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 5,700 92,224 6.59 53.60 305,520 4,943,206
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 3,800 86,524 4.59 44.16 167,808 3,820,900
2012-12-10 2012-12-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 3,000 82,724 3.76 46.34 139,020 3,833,430
2012-10-26 2012-10-25 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -2,500 79,724 -3.04 65.76 -164,400 5,242,650
2012-10-26 2012-10-25 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,500 82,224 -1.79 65.76 -98,642 5,407,132
2012-06-05 2012-06-01 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 10,100 10,100
2012-06-05 2012-06-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 5,500 83,724 7.03
2012-05-18 2012-05-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -1,797 78,224 -2.25 62.55 -112,402 4,892,911
2012-03-13 2012-03-09 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -200 80,021 -0.25 57.78 -11,556 4,623,693
2012-03-13 2012-03-09 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -3,516 80,221 -4.20 57.78 -203,154 4,635,169
2012-03-13 2012-03-09 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,434 83,737 -1.68 57.77 -82,844 4,837,570
2012-03-13 2012-03-09 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -3,600 85,171 -4.06 57.77 -207,972 4,920,329
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,507 88,771 -1.67 56.75 -85,527 5,038,021
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -5,430 90,278 -5.67 57.04 -309,727 5,149,457
2012-02-22 2012-02-17 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 48,100 48,100
2012-02-22 2012-02-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 26,700 95,708 38.69
2010-05-19 2010-05-17 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 19,000 19,000
2010-05-19 2010-05-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 14,000 54,559 34.52
2010-05-19 2010-05-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 13,000 40,559 47.17
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)